Sarcopenia ICD-10 is M62.84, a billable code that has existed since 1 October 2016. The complications are not in finding it. They are in the Code first note attached to it and in the three codes it gets confused with.
Key takeaways
- M62.84, Sarcopenia, is a billable and specific code. Its applicable term is age-related sarcopenia.
- It carries a Code first instruction for an underlying disease where one applies, pointing to G71.-, G72.- and G73.-.
- M62.84 is not interchangeable with M62.5- (site-specific muscle wasting and atrophy) or with the cachexia codes.
- Using M62.84 for a cachectic patient is clinically inaccurate and audit-prone, because cachexia is disease-driven rather than age-related.
- The code is assignable on provider documentation of sarcopenia. A low grip strength reading on its own is not a diagnosis.
Sarcopenia ICD-10 codes at a glance
| Code | Descriptor | Billable | Assign when |
|---|---|---|---|
| M62.84 | Sarcopenia | Yes | Age-related sarcopenia is documented by the provider |
| M62.5- | Muscle wasting and atrophy, not elsewhere classified | No | Localised wasting or disuse atrophy. A further character for site is required |
| M62.50 | Muscle wasting and atrophy, NEC, unspecified site | Yes | Site is not documented |
| R64 | Cachexia | Yes | Cachexia with no documented underlying cause |
| E88.A | Wasting disease (syndrome) due to underlying condition | Yes | Cachexia attributed to a documented illness, sequenced after it |
Why the code exists
Sarcopenia had no code of its own for most of the life of ICD-10-CM, which is a large part of why it went under-recognised and under-treated. M62.84 arrived on 1 October 2016, and the geriatric medicine community treated it as a landmark rather than as an administrative footnote. Anker, Morley and von Haehling wrote that the new code represents a major step forward in recognising sarcopenia as a disease, and expected it to increase the availability of diagnostic tools and the appetite for developing drugs.
That history explains why the code sits in the musculoskeletal chapter as a disease entity rather than in Chapter 18 with the symptoms. Sarcopenia is coded as a condition, not a finding.
The Code first instruction
This is the part most often missed. M62.84 carries a Code first note for an underlying disease where one applies, giving as examples:
- G71.- primary disorders of muscles
- G72.- other and unspecified myopathies
- G73.- disorders of myoneural junction and muscle disease in diseases classified elsewhere
The phrase "if applicable" is doing the work. Uncomplicated age-related sarcopenia in an otherwise well 82-year-old has no underlying muscle disease to sequence, so M62.84 stands alone. Where the record documents a primary muscle disorder or myopathy, that code leads.
Excludes notes at the M62 level
Category M62 carries an Excludes1 for alcoholic myopathy (G72.1), drug-induced myopathy (G72.0), cramp and spasm (R25.2), myalgia (M79.1-) and stiff-man syndrome (G25.82). Subcategory M62.8 carries an Excludes2 for nontraumatic haematoma of muscle (M79.81).
The Excludes1 entries for alcoholic and drug-induced myopathy are the practically important ones. Muscle loss in a patient with documented alcohol-related or statin-related myopathy is not sarcopenia in the coding sense, however similar it looks on examination.
The three-way distinction coders get wrong
This is the whole audit exposure in one table.
| Sarcopenia | Disuse or localised atrophy | Cachexia | |
|---|---|---|---|
| Driver | Ageing | Immobilisation, denervation, disuse of a body part | Underlying illness and its metabolic response |
| Distribution | Generalised | Site-specific | Systemic |
| Code | M62.84 | M62.5- with a site character | R64, or E88.A when a cause is documented |
Assigning M62.84 to a patient with documented cancer cachexia is the error worth hunting for. It is inaccurate clinically, it sits in the wrong chapter, and it misses the E88.A assignment that the documentation actually supports. Our cachexia ICD-10 guide covers that side of the boundary.
The M62.5- error runs the other way: coding site-specific muscle wasting for a patient whose sarcopenia is generalised. M62.5- requires a further character for site precisely because it describes wasting somewhere in particular.
What documentation supports M62.84
The code is assignable when the provider documents sarcopenia. It is not assignable from a body composition scan, a grip strength value or a gait speed alone, because those are the measurements a clinician uses to reach the diagnosis rather than the diagnosis itself.
Knowing what those measurements are helps when reading a chart. The European consensus updated in 2019 by EWGSOP2 treats low muscle strength as the key characteristic, uses low muscle quantity or quality to confirm the diagnosis, and treats poor physical performance as indicating severe sarcopenia. So a chart with a low grip strength, a confirmatory DXA or bioimpedance measurement, and a provider statement is a well-supported M62.84.
One caveat. The applicable term at M62.84 is age-related sarcopenia, but EWGSOP2 describes sarcopenia as a muscle disease rooted in changes accruing across a lifetime, common in older adults but capable of occurring earlier. Where a younger patient carries the diagnosis, expect scrutiny and make sure the provider documentation stands on its own.
The pathway behind the diagnosis
Sarcopenia is coded as a disease because it behaves like one, and the biology is a large part of why the drug pipeline exists at all.
Myostatin, or GDF-8, restrains skeletal muscle growth and tends to rise with age, which made it an obvious target for age-related muscle loss. The trial record has been more mixed than the rationale suggested, with lean mass gains outpacing functional gains. We cover it in myostatin and sarcopenia and the clinical picture in sarcopenia definition.
Sources
- ICD-10-CM code M62.84, Sarcopenia, AAPC Codify.
- Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. Journal of Cachexia, Sarcopenia and Muscle. 2016;7(5):512-514.
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16-31.
- ICD-10-CM Official Guidelines for Coding and Reporting FY 2026, CMS.
Frequently asked questions
What is the ICD-10 code for sarcopenia?
M62.84. It is billable and specific, and it has been valid since 1 October 2016. Its applicable term is age-related sarcopenia.
Does M62.84 need another code with it?
Only where an underlying muscle disease is documented. The Code first note points to G71.-, G72.- and G73.-, qualified by "if applicable". Uncomplicated age-related sarcopenia is reported with M62.84 alone.
Can I use M62.84 for a patient with cancer cachexia?
No. Cachexia is disease-driven systemic wasting and belongs at R64 or, where the underlying condition is documented, at E88.A sequenced after that condition. Substituting the sarcopenia code is inaccurate and is the kind of mismatch an audit picks up.
What is the difference between M62.84 and M62.5-?
M62.84 is generalised age-related sarcopenia. M62.5- is muscle wasting and atrophy not elsewhere classified, which is site-specific and requires a further character for the body part. Disuse atrophy of an immobilised limb belongs in M62.5-, not at M62.84.
Can a grip strength result alone support the code?
No. Measurements support a clinician's diagnosis but do not substitute for it. Assign M62.84 when the provider has documented sarcopenia, and query where the measurements point that way but the diagnosis has not been stated.
This article is for coding education only and is not medical advice or a substitute for the official code set. Always verify assignments against the current fiscal year ICD-10-CM Alphabetic Index, Tabular List and Official Guidelines, together with your organisation's coding policies and any applicable payer rules.